top of page

SAMHSA releases guidance for law enforcement and first responders regarding naloxone

  • Ann Tucker
  • May 28, 2020
  • 1 min read

The Substance Abuse and Mental Health Services Administration (SAMHSA) released new guidance for law enforcement and first responders administering naloxone during the COVID-19 pandemic.


The guidance references reports that some first responders and law enforcement officers have been reluctant to administer naloxone due to fears of contracting COVID-19. SAMHSA reiterated the importance of the lifesaving drug, comparing a reluctance to administer naloxone with withholding CPR from an unresponsive person, and provided several recommendations. SAMHSA noted that the use of intranasal naloxone should still be considered as most law enforcement and first responders are using Personal Protective Equipment (PPE). For those who feel the intranasal approach poses too great a risk, SAMHSA noted the availability of intramuscular naloxone.

 
 
 

Recent Posts

See All

Комментарии


Subscribe to the CLASPP Newsletter

Our members and supporters stay informed. From state and federal policy news to training and webinar events, funding opportunities and more, CLASPP brings it to you first.

Thanks for submitting!

© 2022 by CLASPP

bottom of page